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Article / Clinical Case Report
ABSTRACT
Pleomorphic hyalinizing angiectatic tumor (PHAT) is a rare tumor of uncertain tissue origin. Although it has been classified 
as a benign tumor under the WHO classification, it is locally aggressive, and multiple recurrences have been reported. 
PHAT commonly involves the lower extremities; however, various unusual sites of origin have been reported. We present 
the case of a 30-year-old female with dysmenorrhea, who presented a presacral mass on imaging. The core biopsy 
confirmed the diagnosis of PHAT. She underwent laparotomy and excision. Histopathology confirmed the presence 
of a tumor comprised of aggregates of ectatic vessels with perivascular hyalinization. An immunohistochemical study 
showed diffuse CD34 positivity, but S100, MDM2, and smooth muscle actin negativity. After surgical procedures, the 
patient is disease free as at the 12-month follow-up. Only 120 cases have been published in the English literature to date. 
Our study is only the third case of PHAT arising from the pelvis to be reported. Though considered to be a rare condition, 
the diagnosis of PHAT should always be considered in the differential diagnosis of well-defined hypervascular soft tissue 
mass in the pelvis. The typical histopathological findings along with immunohistochemistry should clinch the diagnosis. 
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CASE REPORT
A 30-year-old female presented complaining of 
dysmenorrhea for 1 year. She had normal bladder 
and bowel habits. A pelvic examination revealed 
an extra-rectal mass on the right para-rectal space, 
pushing the uterus towards the left side. The rectal 
mucosa was normal. Contrast-enhanced computed 
tomography of the abdomen and pelvis showed the 
presence of a well-defined mass with heterogenous 
contrast-enhancement in the left presacral area 
abutting the left lateral wall of the rectum (Figure 1).
A guided core needle biopsy confirmed PHAT. 
An exploratory laparotomy was performed, followed 
by a wide excision of the mass, and hysterectomy and 
bilateral salpingo-oophorectomy. At the 12-month 
follow-up the patient was well with no evidence of 
relapsed disease.
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On gross examination, a globular and capsulated 
mass measuring 7.5 × 6 × 4.5 cm was identified. 
The cut surface was solid with small cystic spaces and 
large areas of hemorrhage without any necrosis or 
calcification (Figure 2).
Microscopic examination revealed the presence 
of a well-encapsulated tumor composed of numerous 
ecstatic vascular channels with fibrin deposition, 
myxoid change, and hyaline degeneration (Figure 3). 
On immunohistochemistry, the stromal cells were diffusely 
positive for CD34, but negative for S100, smooth muscle 
actin, and MDM2 (Figure 4A,4B). The MIB1 labeling index 
was approximately 1%–2% in the highest proliferating 
areas (Figure 4C). Perl Prussian blue staining demonstrated 
iron deposits in the lesion (Figure 4D). With these findings, 
the final diagnosis of PHAT was made.
Figure 1. A and B – Pelvic computed tomography after contrast medium injection revealing heterogeneously 
enhancing mass in the pelvis abutting the lateral wall of rectum with clear fat planes with uterus.
Figure 2. Gross examination of the tumor revealing a globular encapsulated mass measuring 7.6 × 4.5 cm. The cut 
surface shows predominantly a solid mass with small cystic spaces and areas of hemorrhage.
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DISCUSSION
Pleomorphic hyalinizing angiectatic tumor (PHAT) 
is a rare spindle cell neoplasm with an uncertain 
cell of origin. PHAT has a predilection for involving 
subcutaneous tissues, most commonly those of the 
extremities. However, there are case reports describing 
PHAT arising from buccal mucosa, perineum, scrotum, 
and renal hilum.1,2 To date, this is the third PHAT to 
be described in the pelvic region.
Figure 3. Photomicrographs of the tumor. A – Ectatic hyalinized vessels and intervening spindle shaped stromal cells 
(H&E, 40X). B – Infiltration of mixed inflammatory cells into the stroma (H&E, 40X).
Figure 4. Photomicrographs of the tumor showing the stromal cells diffusely and strongly positive for CD34 (A), 
while negative for S100 (B). C – The MIB1with 1%-2% of positivity. D – Perl Prussian blue staining demonstrates 
intracytoplasmic and extra cellular iron deposition.
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PHAT has been classified as a benign tumor 
with uncertain tissue of differentiation according to 
the latest WHO classification of soft tissue tumors.3 
Since its first description, approximately 120 cases of 
PHAT have been described in the English literature.4 
The largest series, to date, was described by Folpe and 
Weiss5 and included 41 cases. The median age of onset 
is 53 years, ranging from 10 to 83 years. There is a 
female to male preponderance (4:3) with subcutaneous 
tissue the most common area, and the lower extremity 
the most common location. Other less frequently 
affected sites include the trunk, upper extremities, 
axilla, inguinal region, perineum, buttock, back, oral 
cavity, and scrotum.6 Various studies have shown local 
recurrence rates of 30%-50% on long-term follow-up. 
However, no metastases have been documented. 
Previously, only two cases of PHAT arising from the 
pelvic cavity have been described (Table 1).
The most striking feature of this tumor is the 
hyalinizing angioectatic vasculature. Smith et al.9 had 
proposed two theories regarding the formation of 
hyalinized vessels. The first mechanism suggests that 
tissue injury caused by tumor infiltration may lead 
to the release of vasoactive mast cell products with 
subsequent increased vascular permeability within 
the tumor. The second mechanism postulates that 
the encroachment of the advancing tumor on normal 
vessels may cause endothelial damage and exudation of 
plasma contents with subsequent organization, leading 
to the formation of perivascular hyaline deposits. 
Folpe and Weiss5 proposed that the vascular changes 
occur very early even without significant spindle cell 
proliferation. Further, the characteristic pleomorphism 
of classic PHAT is a late, time-dependent, degenerative 
phenomenon.
Studies have shown that PHAT tumor cells 
consistently express vimentin, CD34, and vascular 
endothelial growth factor.10 Less frequently, CD99 
and Factor XIIIa are expressed. The tumor cells were 
consistently negative for CD68, actin, desmin, and 
S100. Differentiation from Schwannoma is based on 
S100 negativity. Immunostaining for vimentin, CD34, 
and CD99 has failed to suggest a clear cell of origin. 
In the present case, on immunostaining the tumor 
cells were diffusely positive for CD34 and negative for 
S100, SMA, and MDM2.
Our imaging finding of a well-defined mass 
with heterogeneous contrast enhancement and 
many surrounding dilated vessels is similar to 
other published reports8,11 (Figure 1). This may be 
considered as a common imaging feature of PHAT. 
The presence of high-density areas on non-contrast 
computed tomography (CT), which did not show any 
enhancement, was probably due to hemorrhage within 
the lesion, and was confirmed by the histopathologic 
study.
Chu et al.12 reported the magnetic resonance 
imaging features as a well-defined mass showing 
isointense and slight hypointense on T1-weighted 
images, and isointense and hyperintense on T2 
weighted images. Contrast enhanced images showed 
heterogenous enhancement with large vessels showing 
flow void sign. Positron emission tomography-CT 
revealed a well-defined mass with no FDG uptake 
correlating with the low mitotic rate.
Though PHAT has a low mitotic rate and an 
absence of documented metastases, aggressive 
recurrences can lead to significant morbidity. Therefore, 
it is considered to be a borderline (intermediate grade) 
soft tissue sarcoma rather than a benign one. A high 
recurrence rate of 30%–50% has been documented 
with the majority of cases being marginally resected.10 
Folpe and Weiss5 described a case of PHAT recurring 
as a case of myxoid pleomorphic sarcoma 4 years later 
in the same location.
Table 1. Case reports of pelvic PHAT
Case report Location Age/sex Presentation Treatment Follow-up
Iascone7 Mesorectum 53/F Asymptomatic Laparotomy and 
excision
Recurrence-free at 58 months
Chu et al.8 Pelvic 
retroperitoneum
26/F Incidental Excision Recurrence-free at 18 months
Index case Mesorectum 30/F Dysmenorrhea Laparotomy and 
excision + hysterectomy 
+ BL SPO
Recurrence-free at 12 months
BL SPO = bilateral salpingo-oophorectomy; F = female; PHAT = pleomorphic hyalinizing angiectatic tumor.
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Currently, the standard treatment for extremity 
PHAT is wide local excision with a tumor-free margin. 
In pelvic PHAT, a tumor-free margin can be considered 
adequate. Due to the small number of cases, there is 
no robust evidence of the role of adjuvant therapy in 
PHAT. Adjuvant radiotherapy has been used in various 
case series to decrease the local recurrence rate, but 
further evidence is required before advocating its use.8 
Chemotherapy has no role in view of the absence of 
any distant metastases.
CONCLUSION
Although PHAT in the pelvis is a rare diagnosis, the 
increasing number of reported cases should prompt the 
surgeon to consider PHAT as a differential diagnosis 
with characteristic pathological findings. Wide excision 
of the tumor with adequate margins is the mainstay 
of the treatment. The role of any adjuvant treatment 
has not been proven. Further research on the topic has 
been stagnant due to the rarity of this tumor.
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